Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, tolerability, and pharmacokinetics of AGN-190168 in adults with acne vulgaris; the study has completed enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AGN-190168

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED